Jiang Jiu-kun, Lin Xu-ai, Yan Jie
Department of Microbiology and Parasitology, College of Medicine, Zhejiang University, and State Key Laboratory for Diagnosis and Treatment of Infectious Diseases, The First Affiliated Hospital, Hangzhou 310058, China.
Zhejiang Da Xue Xue Bao Yi Xue Ban. 2008 Nov;37(6):585-91. doi: 10.3785/j.issn.1008-9292.2008.06.008.
To predict and screen the efficient antigenic epitopes in genus-specific envelope protein LipL41 of Leptospira interrogans and to determine the immunoreactive diversity of LipL41s from different genotypes.
Bioinformatic methods were applied to predict the T/B combined epitope candidates in LipL41/1 and LipL41/2 molecules. The nucleotide fragments encoding epitopes were amplified by PCR. Phage display system with SDS-PAGE was performed to obtain the recombinant PIIIs containing different T/B combined epitopes. Western Blot assays were performed to determine the immunoreactivity of recombinant PIIIs to various antisera including antiserum against rLipL41/1, rLipL41/2 and whole cell of L.interrogans strain Lai, and serum from patients with leptospirosis.
Based on the predicting data, eight common or differential combined epitopes in LipL41s were selected. The nucleotide fragments encoding the epitopes were obtained by PCR. All the T/B combined epitope fragments were correctly inserted into the N end of phage PIII protein and then successfully expressed. All the antisera were able to recognize each of the epitopes but the hybridization signal intensity was different. Among these epitopes, the common T/B combined epitopes LipL41/1-30 and LipL41/1-233 showed a stronger and stable hybridization signals.
All 8 selected T/B combined epitopes in the study are the efficient antigenic epitopes. The common T/B epitopes LipL41/1-30 and LipL41/1-233 can be first used in development of leptospiral MAP vaccine. The cross immunoreaction is between the differential T/B epitopes LipL41s-89,LipL41s-299 and the different antisera.
预测并筛选问号钩端螺旋体属特异性外膜蛋白LipL41中的有效抗原表位,确定不同基因型LipL41的免疫反应多样性。
应用生物信息学方法预测LipL41/1和LipL41/2分子中的T/B联合表位候选序列。通过PCR扩增编码表位的核苷酸片段。利用噬菌体展示系统结合SDS-PAGE获得含有不同T/B联合表位的重组PIII。进行Western Blot分析以确定重组PIII对多种抗血清的免疫反应性,包括抗rLipL41/1、rLipL41/2抗血清以及针对问号钩端螺旋体赖型全菌的抗血清,还有钩端螺旋体病患者血清。
根据预测数据,选择了LipL41中8个共同或差异的联合表位。通过PCR获得了编码这些表位的核苷酸片段。所有T/B联合表位片段均正确插入噬菌体PIII蛋白的N端并成功表达。所有抗血清均能识别每个表位,但杂交信号强度不同。在这些表位中,共同的T/B联合表位LipL41/1-30和LipL41/1-233显示出更强且稳定的杂交信号。
本研究中选择的所有8个T/B联合表位均为有效抗原表位。共同的T/B表位LipL41/1-30和LipL41/1-233可首先用于钩端螺旋体多抗原肽疫苗的研发。差异T/B表位LipL41s-89、LipL41s-299与不同抗血清之间存在交叉免疫反应。